Inari Medical Inc (NARI) Actualités

Inari Medical to Participate in the Jefferies London Healthcare Conference

IRVINE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism

IRVINE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Inari Medical Reports Third Quarter 2024 Financial Results

IRVINE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Okami Medical Announces Closing Of $32.5M Financing

Okami Medical Announces Closing Of $32.5M Financing PR Newswire ALISO VIEJO, Calif., Oct. 21, 2024 ALISO...

Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial

IRVINE, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- In recognition of World Thrombosis Day, Inari Medical, Inc...

Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation

IRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical...

Inari Medical to Announce Third Quarter 2024 Financial Results

IRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities